Hannah J. Kim

Vancouver, BC V6H3N1, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status.

Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status.

Journal: International journal of molecular sciences

Published: December 13, 2025

Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.

Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.

Journal: The Journal of pathology

Published: November 25, 2025

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.

Journal: The Journal of pathology

Published: October 28, 2025

Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations.

Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations.

Journal: Translational oncology

Published: August 28, 2025

Reducing public stigma toward bipolar disorder: I. Interventions and outcomes.

Reducing public stigma toward bipolar disorder: I. Interventions and outcomes.

Journal: Journal of affective disorders

Published: January 22, 2025

Reducing public stigma toward bipolar disorder: II. Mechanisms of stigma reduction.

Reducing public stigma toward bipolar disorder: II. Mechanisms of stigma reduction.

Journal: Journal of affective disorders

Published: January 22, 2025

Covert or connected: Motivations for online and interpersonal reassurance-seeking in OCD.

Covert or connected: Motivations for online and interpersonal reassurance-seeking in OCD.

Journal: Journal of anxiety disorders

Published: November 14, 2024

FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma.

FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma.

Journal: Journal of gynecologic oncology

Published: August 21, 2024

Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.

Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.

Journal: Gynecologic oncology

Published: March 28, 2024

High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma.

High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma.

Journal: Scientific data

Published: March 18, 2024

High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.

High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.

Journal: Gynecologic oncology

Published: February 06, 2024

Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45].

Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45].

Journal: Gynecologic oncology

Published: October 18, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026